Table 1. Patients characteristics.
| Characteristic | Value No. (%) |
|---|---|
| All | 224 (100) |
| Age, mean ± SD | 68.8 ± 7.2 |
| WHO | |
| 0 | 92 (41) |
| 1 | 130 (58) |
| Missing | 2 (1) |
| Type castration | |
| Surgical | 30 (13) |
| LHRH-analogue | 194 (87) |
| No. prior therapies | |
| 1 | 204 (91) |
| ≥2 | 20 (9) |
| Months since last chemotherapy | |
| ≤6 months | 102 (46) |
| >6 months | 122 (54) |
| Baseline laboratory results | Median (IQR) |
| Hb (mmol/L) | 7.7 (6.8–8.2) |
| Albumin (g/L) | 39.0 (36.0–43.0) |
| AP (U/L) | 130.0 (86.0–262.0) |
| LDH (U/L) | 271.0 (210.0–392.0) |
| ANC (109/L) | 5.9 (4.4–7.6) |
| PSA (g/L) | 154.1 (59–388.3) |
| dNLR | 2.7 (1.8–3.9) |
Abbreviations: WHO = world health organization, Hb = hemoglobin, AP = Alkaline Phosphatase, LDH = lactate dehydrogenase, ANC = absolute neutrophil count, PSA = prostate specific antigen, dNLR = derived Neutrophil-Lymphocyte ratio.